Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 365

1.

Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.

Shimoni A, Vago L, Bernardi M, Yerushalmi R, Peccatori J, Greco R, Shem-Tov N, Lo Russo A, Danylesko I, Apel A, Bonini C, Lupo Stanghellini MT, Nagler A, Ciceri F.

Am J Hematol. 2017 Oct;92(10):1011-1019. doi: 10.1002/ajh.24827. Epub 2017 Jul 19.

PMID:
28631269
2.

Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation.

Ogonek J, Verma K, Schultze-Florey C, Varanasi P, Luther S, Schweier P, Kühnau W, Göhring G, Dammann E, Stadler M, Ganser A, Koehl U, Koenecke C, Weissinger EM, Hambach L.

J Immunol. 2017 Jul 15;199(2):792-805. doi: 10.4049/jimmunol.1601992. Epub 2017 Jun 19.

PMID:
28630092
3.

Gene Therapy for β-Hemoglobinopathies.

Cavazzana M, Antoniani C, Miccio A.

Mol Ther. 2017 May 3;25(5):1142-1154. doi: 10.1016/j.ymthe.2017.03.024. Epub 2017 Apr 1. Review.

PMID:
28377044
4.

Anti-HLA Antibody Levels Are Associated With the Risk of Graft Failure After Allogeneic Hematopoietic Stem Cell Transplant.

Basturk B, Kasar M, Yeral M, Kavuzlu M.

Exp Clin Transplant. 2017 Feb;15(Suppl 1):219-223.

5.

Mismatched HLA-DRB3 Can Induce a Potent Immune Response After HLA 10/10 Matched Stem Cell Transplantation.

van Balen P, van Luxemburg-Heijs SAP, van de Meent M, van Bergen CAM, Halkes CJM, Jedema I, Falkenburg JHF.

Transplantation. 2017 Dec;101(12):2850-2854. doi: 10.1097/TP.0000000000001713.

PMID:
28252558
6.

Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect.

Orti G, Barba P, Fox L, Salamero O, Bosch F, Valcarcel D.

Exp Hematol. 2017 Apr;48:1-11. doi: 10.1016/j.exphem.2016.12.004. Epub 2016 Dec 24. Review.

PMID:
28027963
7.

Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.

Rogatko-Koroś M, Mika-Witkowska R, Bogunia-Kubik K, Wysoczańska B, Jaskuła E, Kościńska K, Nestorowicz K, Dziopa J, Szlendak U, Gwozdowicz S, Graczyk-Pol E, Lange A, Nowak J.

Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):63-71. doi: 10.1007/s00005-016-0438-2. Epub 2016 Dec 8.

PMID:
27933342
8.

Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Baron F, Mohty M, Blaise D, Socié G, Labopin M, Esteve J, Ciceri F, Giebel S, Gorin NC, Savani BN, Schmid C, Nagler A.

Haematologica. 2017 Feb;102(2):224-234. doi: 10.3324/haematol.2016.148510. Epub 2016 Dec 7. Review.

9.

Recombinant MHC Tetramers for Isolation of Virus-Specific CD8<sup>+</sup> Cells from Healthy Donors: Potential Approach for Cell Therapy of Posttransplant Cytomegalovirus Infection.

Vdovin AS, Filkin SY, Yefimova PR, Sheetikov SA, Kapranov NM, Davydova YO, Egorov ES, Khamaganova EG, Drokov MY, Kuzmina LA, Parovichnikova EN, Efimov GA, Savchenko VG.

Biochemistry (Mosc). 2016 Nov;81(11):1371-1383.

10.

Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation.

Fuerst D, Neuchel C, Niederwieser D, Bunjes D, Gramatzki M, Wagner E, Wulf G, Glass B, Pfreundschuh M, Einsele H, Arnold R, Stuhler G, Schaefer-Eckart K, Freitag S, Casper J, Kaufmann M, Wattad M, Hertenstein B, Klein S, Ringhoffer M, Mytilineos D, Tsamadou C, Mueller C, Schrezenmeier H, Mytilineos J.

Blood. 2016 Dec 29;128(26):3169-3176. doi: 10.1182/blood-2016-05-716357. Epub 2016 Nov 3.

11.

Selecting the best haploidentical donor.

McCurdy SR, Fuchs EJ.

Semin Hematol. 2016 Oct;53(4):246-251. doi: 10.1053/j.seminhematol.2016.08.001. Epub 2016 Aug 15. Review.

PMID:
27788762
12.

Matched unrelated donor transplants-State of the art in the 21st century.

Altaf SY, Apperley JF, Olavarria E.

Semin Hematol. 2016 Oct;53(4):221-229. doi: 10.1053/j.seminhematol.2016.07.002. Epub 2016 Jul 25. Review.

PMID:
27788759
13.

Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection.

Tischer S, Geyeregger R, Kwoczek J, Heim A, Figueiredo C, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B.

J Transl Med. 2016 Oct 7;14(1):286.

14.

Identification of a novel HLA-B*07 variant, B*07:269, by sequence-based typing in a Taiwanese bone marrow stem cell donor.

Yang KL, Lin PY.

HLA. 2016 Oct;88(4):198-9. doi: 10.1111/tan.12879. Epub 2016 Aug 31.

PMID:
27581230
15.

Identification of a novel HLA-A*02 variant, HLA-A*02:621, in a Taiwanese bone marrow donor.

Yang KL, Chen SP, Lin PY.

HLA. 2016 Oct;88(4):194-5. doi: 10.1111/tan.12865. Epub 2016 Aug 23.

PMID:
27554757
16.

Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia.

Choi I, Yoon SR, Park SY, Kim H, Jung SJ, Kang YL, Lee JH, Lee JH, Kim DY, Lee JL, Park HS, Choi EJ, Lee YS, Kang YA, Jeon M, Seol M, Baek S, Yun SC, Kim HJ, Lee KH.

Biol Blood Marrow Transplant. 2016 Nov;22(11):2065-2076. doi: 10.1016/j.bbmt.2016.08.008. Epub 2016 Aug 12.

17.

Discovery of HLA-B*58:80, a novel HLA-B*58 variant, in a Taiwanese bone marrow donor.

Yang KL, Hung JH, Lin PY.

HLA. 2016 Sep;88(3):127-9. doi: 10.1111/tan.12861. Epub 2016 Aug 11.

PMID:
27514362
18.

Discovery of a novel HLA-DRB1*09 variant, HLA-DRB1*09:28, in a Taiwanese individual.

Yang KL, Hung JH, Lin PY.

HLA. 2016 Sep;88(3):129-30. doi: 10.1111/tan.12854. Epub 2016 Aug 8.

PMID:
27501346
19.

HapLogic: A Predictive Human Leukocyte Antigen-Matching Algorithm to Enhance Rapid Identification of the Optimal Unrelated Hematopoietic Stem Cell Sources for Transplantation.

Dehn J, Setterholm M, Buck K, Kempenich J, Beduhn B, Gragert L, Madbouly A, Fingerson S, Maiers M.

Biol Blood Marrow Transplant. 2016 Nov;22(11):2038-2046. doi: 10.1016/j.bbmt.2016.07.022. Epub 2016 Aug 2.

20.

HLA-DRB1*16:39, a novel HLA-DRB1*16 variant, discovered in a Taiwanese bone marrow hematopoietic stem cell donor.

Yang KL, Hung JH, Lin PY.

HLA. 2016 Sep;88(3):124-5. doi: 10.1111/tan.12853. Epub 2016 Aug 3.

PMID:
27488973

Supplemental Content

Loading ...
Support Center